Literature DB >> 25166397

First-order superconducting transition of Sr2RuO4.

Shingo Yonezawa1, Tomohiro Kajikawa1, Yoshiteru Maeno1.   

Abstract

By means of the magnetocaloric effect, we examine the nature of the superconducting-normal (S-N) transition of Sr(2)RuO(4), a most promising candidate for a spin-triplet superconductor. We provide thermodynamic evidence that the S-N transition of this oxide is of first order below approximately 0.8 K and only for magnetic field directions very close to the conducting plane, in clear contrast to the ordinary type-II superconductors exhibiting second-order S-N transitions. The entropy release across the transition at 0.2 K is 10% of the normal-state entropy. Our result urges an introduction of a new mechanism to break superconductivity by magnetic field.

Entities:  

Year:  2013        PMID: 25166397     DOI: 10.1103/PhysRevLett.110.077003

Source DB:  PubMed          Journal:  Phys Rev Lett        ISSN: 0031-9007            Impact factor:   9.161


  3 in total

1.  Evidence for even parity unconventional superconductivity in Sr2RuO4.

Authors:  Aaron Chronister; Andrej Pustogow; Naoki Kikugawa; Dmitry A Sokolov; Fabian Jerzembeck; Clifford W Hicks; Andrew P Mackenzie; Eric D Bauer; Stuart E Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-22       Impact factor: 11.205

2.  Direct penetration of spin-triplet superconductivity into a ferromagnet in Au/SrRuO3/Sr2RuO4 junctions.

Authors:  M S Anwar; S R Lee; R Ishiguro; Y Sugimoto; Y Tano; S J Kang; Y J Shin; S Yonezawa; D Manske; H Takayanagi; T W Noh; Y Maeno
Journal:  Nat Commun       Date:  2016-10-26       Impact factor: 14.919

3.  Unsplit superconducting and time reversal symmetry breaking transitions in Sr2RuO4 under hydrostatic pressure and disorder.

Authors:  Vadim Grinenko; Debarchan Das; Ritu Gupta; Bastian Zinkl; Naoki Kikugawa; Yoshiteru Maeno; Clifford W Hicks; Hans-Henning Klauss; Manfred Sigrist; Rustem Khasanov
Journal:  Nat Commun       Date:  2021-06-24       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.